Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Green Tea Polyphenol in De Novo Parkinson's Disease
NCT00461942Phase 2Completed
- Sponsor
- Xuanwu Hospital
- Start
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of green tea catechin extract in Parkinson's disease (PD) (4 arms), sponsored by Xuanwu Hospital. Primary endpoint: Unified Parkinson's Disease Rating Scale at 1 year. Started Apr 2006; status: completed.
02
Drugs
green tea catechin extract
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00461942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00461942.